Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP

被引：3
|
作者：
Adams, Hugo J. A. [1 ]
Kwee, Thomas C. [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol Nucl Med & Mol Imaging, Groningen, Netherlands
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 185卷 / 04期
关键词：
FDG-PET; Hodgkin lymphoma; POSITRON-EMISSION-TOMOGRAPHY;
D O I：
10.1111/bjh.15602
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：758 / 760
页数：3
相关论文
共 50 条
  • [11] Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2016, 33 (01) : 1 - 4
  • [12] Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
    Gallamini, Andrea
    Patti, Caterina
    Viviani, Simonetta
    Rossi, Andrea
    Fiore, Francesca
    Di Raimondo, Francesco
    Cantonetti, Maria
    Stelitano, Caterina
    Feldman, Tatyana
    Gavarotti, Paolo
    Sorasio, Roberto
    Mule, Antonino
    Leone, Monica
    Rambaldi, Alessandro
    Biggi, Alberto
    Barrington, Sally
    Fallanca, Federico
    Ficola, Umberto
    Chauvie, Stephane
    Gianni, Alessandro Massimo
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 551 - 560
  • [13] High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan
    Kedmi, Meirav
    Apel, Arie
    Davidson, Tima
    Levi, Itai
    Dann, Eldad J.
    Polliack, Aaron
    Ben-Bassat, Isaac
    Nagler, Arnon
    Avigdor, Abraham
    ACTA HAEMATOLOGICA, 2016, 135 (03) : 156 - 161
  • [14] Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
    Adams, Hugo J. A.
    Kwee, Thomas C.
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (12) : 1333 - 1334
  • [15] EARLY INTERIM FDG-PET DURING INTESIFIED BEACOPP THERAPY FOR ADVANCED-STAGE HODGKIN DISEASE SHOWS A LOWER POSITIVE PREDICTIVE VALUE THAN DURING ABVD
    Fiore, F.
    Viviani, S.
    Luminari, S.
    Levis, A.
    Di Raimondo, F.
    Merli, F.
    Vitolo, U.
    Bolis, S.
    Federico, M.
    Gallamini, A.
    HAEMATOLOGICA, 2010, 95 : S18 - S18
  • [16] INTERIM FDG-PET/CT DOES NOT PREDICT OUTCOME IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY ALONE OR ASCT
    Ribakovsky, E.
    Kedmi, M.
    Avivi, I.
    Benyamini, N.
    Davidson, T.
    Goshen, E.
    Bar Shalom, R.
    Tadmor, T.
    Nagler, A.
    Avigdor, A.
    HAEMATOLOGICA, 2012, 97 : 102 - 102
  • [17] EARLY AND LATE RESPONSE ASSESSMENT WITH FDG-PET AFTER BEACOPP-BASED CHEMOTHERAPY IN ADVANCED-STAGE HODGKIN LYMPHOMA PATIENTS HAS A HIGH NEGATIVE PREDICTIVE VALUE
    Markova, J.
    Kobe, C.
    Skopalova, M.
    Zikavska, L.
    Vernerova, Z.
    Klaskova, K.
    Dedeckova, K.
    Eich, H. T.
    Dietlein, M.
    Fuchs, M.
    Engert, A.
    Kozak, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 33 - 33
  • [18] The Complementary Prognostic Role of Baseline and Interim PET in Predicting Treatment Outcome in Advanced-Stage Hodgkin Lymphoma
    Cimino, Giuseppe
    Zaucha, Jan Maciej
    Cirillo, S.
    Saviolo, C.
    Hutchings, Martin
    El-Galaly, T. C.
    Borra, Anna
    Rago, Angela
    Gallamini, Andrea
    BLOOD, 2014, 124 (21)
  • [19] Predictive Value of Interim 18FDG-PET on Treatment Outcome in Advanced-Stage Hodgkin's Disease
    Castagnoli, A.
    Rigacci, L.
    Versari, A.
    Gallamini, A.
    Matteini, M.
    Merli, F.
    Nassi, L.
    Peano, S.
    Pelosi, E.
    Gregianin, M.
    Vaggelli, L.
    Levis, A.
    Biggi, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S24 - S24
  • [20] EARLY INTERIM FDG-PET IN ADVANCED-STAGE HODGKIN LYMPHOMA (HL). LONG-TERM RESULTS OF THE ITALIAN-DANISH COOPERATIVE STUDY
    Gallamini, A.
    Hutchings, M.
    Rigacci, L.
    Specht, L.
    Merli, F.
    Hansen, M.
    Patti, C.
    Loft, A.
    Di Raimondo, F.
    D'Amore, F.
    Biggi, A.
    Pregno, P.
    Stelitano, C.
    Sancetta, R.
    Trentin, L.
    Luminari, S.
    Iannitto, E.
    Viviani, S.
    Pierri, I.
    Torchio, P.
    Levis, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 191 - 191
12345